DIGITAL EDITION

ARCHIVES

CURRENT ISSUE

Lisdexamfetamine Dimesylate for the Treatment of Attention Deficit Hyperactivity Disorder in Adults With a History of Depression or History of Substance Use Disorder

by Scott H. Kollins, PhD; Sharon Youcha, MD; Robert Lasser, MD, MBA; and Michael E. Thase, MD Dr. Kollins is from Duke ADHD Program, Duke University Medical Center, Durham, North